Physician profile
Daniel L West
NPI 1154315505
$2,801.90
in general payments reported to CMS, 2019-2025
19 companies · $744 in 2025
The $744 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $248 · 2021: $54.71 · 2022: $492 · 2023: $479 · 2024: $677 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $454.59 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Medtronic, INC. | $433.20 | 2021-2024 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Pfizer INC. | $398.18 | 2022-2025 | |
| Atricure, INC. | $371.49 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abiomed | $285.86 | 2020-2024 | Impella |
| Boston Scientific Corporation | $154.22 | 2020 | |
| Heartflow, INC. | $124.65 | 2023 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.57 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $109.19 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $95.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $91.97 | 2021-2022 | |
| Shockwave Medical, INC | $29.02 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $28.52 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $25.40 | 2019 | |
| Bard Peripheral Vascular, INC. | $21.39 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $20.85 | 2020 | |
| Novo Nordisk INC | $17.82 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $13.14 | 2019 | |
| Terumo Medical Corporation | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.